标题
Management of VEGF-Targeted Therapy-Induced Hypertension
作者
关键词
VEGF, Hypertension, Vascular endothelial growth factors, Tumors
出版物
CURRENT HYPERTENSION REPORTS
Volume 20, Issue 8, Pages -
出版商
Springer Nature
发表日期
2018-06-29
DOI
10.1007/s11906-018-0871-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- VEGFR (Vascular Endothelial Growth Factor Receptor) Inhibition Induces Cardiovascular Damage via Redox-Sensitive ProcessesNovelty and Significance
- (2018) Karla B. Neves et al. HYPERTENSION
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
- (2018) Paul K. Whelton et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events
- (2018) Rhian M. Touyz et al. Journal of the American Society of Hypertension
- Hypertension and VEGF (Vascular Endothelial Growth Factor) Receptor Tyrosine Kinase InhibitionNovelty and Significance
- (2017) Brian C. Boursiquot et al. HYPERTENSION
- Salt Sensitivity of Angiogenesis Inhibition–Induced Blood Pressure RiseNovelty and Significance
- (2017) Stephanie Lankhorst et al. HYPERTENSION
- Cardio-Oncology
- (2017) Javid Moslehi et al. HYPERTENSION
- Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition
- (2017) Rhian M. Touyz et al. HYPERTENSION
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- (2017) Paul K. Whelton et al. HYPERTENSION
- Microvascular structure as a prognostically relevant endpoint
- (2017) Enrico Agabiti-Rosei et al. JOURNAL OF HYPERTENSION
- Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data
- (2016) Michael J Sorich et al. BRITISH JOURNAL OF CANCER
- Vascular Complications of Cancer Chemotherapy
- (2016) Alan C. Cameron et al. CANADIAN JOURNAL OF CARDIOLOGY
- Long-term arterial complications of chemotherapy in patients with cancer
- (2016) Tone Svilaas et al. THROMBOSIS RESEARCH
- Prognostic Impact of Renin–Angiotensin System Blockade on Renal Cell Carcinoma After Surgery
- (2015) Akira Miyajima et al. ANNALS OF SURGICAL ONCOLOGY
- Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma
- (2015) R. R. McKay et al. CLINICAL CANCER RESEARCH
- Aflibercept: A Review in Metastatic Colorectal Cancer
- (2015) Yahiya Y. Syed et al. DRUGS
- Impaired endothelium-dependent vasodilation does not initiate the development of sunitinib-associated hypertension
- (2015) Anna M.J. Thijs et al. JOURNAL OF HYPERTENSION
- Effect of high salt diet on blood pressure and renal damage during vascular endothelial growth factor inhibition with sunitinib
- (2015) Stephanie Lankhorst et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib
- (2014) Stephanie Lankhorst et al. HYPERTENSION
- Systematic Review of the Risk of Adverse Outcomes Associated with Vascular Endothelial Growth Factor Inhibitors for the Treatment of Cancer
- (2014) Labib Imran Faruque et al. PLoS One
- Role of Endogenous Vascular Endothelial Growth Factor in Endothelium-Dependent Vasodilation in Humans
- (2013) Anna M.J. Thijs et al. HYPERTENSION
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
- (2013) Giuseppe Mancia et al. JOURNAL OF HYPERTENSION
- Analysis of Early Hypertension and Clinical Outcome With Bevacizumab: Results From Seven Phase III Studies
- (2013) H. I. Hurwitz et al. ONCOLOGIST
- Cardiovascular complications associated with novel angiogenesis inhibitors: Emerging evidence and evolving perspectives
- (2013) Steven M. Bair et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Regorafenib Induces Rapid and Reversible Changes in Plasma Nitric Oxide and Endothelin-1
- (2012) Nilka de Jesus-Gonzalez et al. AMERICAN JOURNAL OF HYPERTENSION
- Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension
- (2012) Peter Kruzliak et al. ANGIOGENESIS
- Incidence and risk of hypertension with vandetanib in cancer patients: a systematic review and meta-analysis of clinical trials
- (2012) Wei-Xiang Qi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Incidence and risk of hypertension with pazopanib in patients with cancer: a meta-analysis
- (2012) Wei-Xiang Qi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Management of Antiangiogenic Therapy-Induced Hypertension
- (2012) Nilka de Jesus-Gonzalez et al. HYPERTENSION
- Endothelin 1 Activation of Endothelin A Receptor/NADPH Oxidase Pathway and Diminished Antioxidants Critically Contribute to Endothelial Progenitor Cell Reduction and Dysfunction in Salt-Sensitive Hypertension
- (2012) Dan-Dan Chen et al. HYPERTENSION
- Mechanism of hypertension and proteinuria during angiogenesis inhibition
- (2012) Stephanie Lankhorst et al. JOURNAL OF HYPERTENSION
- VEGF Inhibition, Hypertension, and Renal Toxicity
- (2012) Suzanne R. Hayman et al. Current Oncology Reports
- Vascular Endothelial Growth Factor (VEGF), VEGF Receptors and Their Inhibitors for Antiangiogenic Tumor Therapy
- (2011) Satoru Takahashi BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination
- (2011) Daniel Keizman et al. EUROPEAN JOURNAL OF CANCER
- The Vascular Endothelial Growth Factor Receptor Inhibitor Sunitinib Causes a Preeclampsia-Like Syndrome With Activation of the Endothelin System
- (2011) Mariëtte H.W. Kappers et al. HYPERTENSION
- Sunitinib-Induced Systemic Vasoconstriction in Swine Is Endothelin Mediated and Does Not Involve Nitric Oxide or Oxidative Stress
- (2011) Mariëtte H.W. Kappers et al. HYPERTENSION
- Cardiovascular toxicity of anti-angiogenic drugs
- (2011) Gaetan des Guetz et al. Targeted Oncology
- Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A Meta-Analysis
- (2010) V. Ranpura et al. AMERICAN JOURNAL OF HYPERTENSION
- Impaired Autonomic Regulation of Resistance Arteries in Mice With Low Vascular Endothelial Growth Factor or Upon Vascular Endothelial Growth Factor Trap Delivery
- (2010) Erik Storkebaum et al. CIRCULATION
- Suppression of the Nitric Oxide Pathway in Metastatic Renal Cell Carcinoma Patients Receiving Vascular Endothelial Growth Factor–Signaling Inhibitors
- (2010) Emily S. Robinson et al. HYPERTENSION
- Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels
- (2010) Mariëtte H.W. Kappers et al. HYPERTENSION
- Treatment of bevacizumab-induced hypertension by amlodipine
- (2010) Olivier Mir et al. INVESTIGATIONAL NEW DRUGS
- Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2
- (2010) Jennifer L. Spratlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors
- (2010) Michael L. Maitland et al. JNCI-Journal of the National Cancer Institute
- Vascular endothelial growth factor receptor inhibitor enhances dietary salt-induced hypertension in Sprague-Dawley rats
- (2009) Jian-Wei Gu et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk
- (2009) P. J. Barrett-Lee et al. ANNALS OF ONCOLOGY
- Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression
- (2009) Carie S. Facemire et al. HYPERTENSION
- Effective Strategies for Management of Hypertension After Vascular Endothelial Growth Factor Signaling Inhibition Therapy: Results From a Phase II Randomized, Factorial, Double-Blind Study of Cediranib in Patients With Advanced Solid Tumors
- (2009) Marlies H.G. Langenberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis
- (2008) Xiaolei Zhu et al. ACTA ONCOLOGICA
- A Novel Human-Specific Soluble Vascular Endothelial Growth Factor Receptor 1
- (2008) Shay Sela et al. CIRCULATION RESEARCH
- Hypertension and Rarefaction during Treatment with Telatinib, a Small Molecule Angiogenesis Inhibitor
- (2008) N. Steeghs et al. CLINICAL CANCER RESEARCH
- Inhibition of Vascular Endothelial Growth Factor-A Signaling Induces Hypertension: Examining the Effect of Cediranib (Recentin; AZD2171) Treatment on Blood Pressure in Rat and the Use of Concomitant Antihypertensive Therapy
- (2008) J. O. Curwen et al. CLINICAL CANCER RESEARCH
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation
- (2007) J.-J. Mourad et al. ANNALS OF ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now